Protalix BioTherapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 3.65 M | $6.56 M | 2.71% | 4.60% |
| OPALEYE MANAGEMENT INC. | 04/13/2026 | 2.48 M | $4.46 M | -3.97% | 3.13% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 1.26 M | $2.27 M | -3.96% | 1.59% |
| NORTHERN TRUST CORP | 02/17/2026 | 865.71 K | $1.56 M | -4.07% | 1.09% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 830.05 K | $1.49 M | 1.25% | 1.05% |
| STATE STREET CORP | 02/13/2026 | 585.26 K | $1.05 M | 17.39% | 0.74% |
| STRATOS WEALTH PARTNERS, LTD. | 01/20/2026 | 500.00 K | $900.00 K | 0.00% | 0.63% |
| VANGUARD GROUP INC | 01/29/2026 | 488.55 K | $879.39 K | 5.20% | 0.62% |
| CITADEL ADVISORS LLC | 02/17/2026 | 317.63 K | $571.73 K | 751.41% | 0.40% |
| JANE STREET GROUP, LLC | 02/12/2026 | 289.92 K | $521.85 K | 100.00% | 0.37% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 262.81 K | $473.06 K | 74.24% | 0.33% |
| UBS GROUP AG | 01/29/2026 | 262.52 K | $472.54 K | 37.97% | 0.33% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 232.09 K | $417.77 K | -42.03% | 0.29% |
| MAIN STREET FINANCIAL SOLUTIONS, LLC | 02/17/2026 | 214.10 K | $385.38 K | 65.84% | 0.27% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 210.87 K | $379.56 K | 52.20% | 0.27% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 189.10 K | $340.38 K | 0.00% | 0.24% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 175.07 K | $315.13 K | 0.00% | 0.22% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/12/2026 | 171.77 K | $309.19 K | 0.00% | 0.22% |
| EVERGREEN CAPITAL MANAGEMENT LLC | 01/27/2026 | 171.34 K | $308.41 K | 0.00% | 0.22% |
| ROUND ROCK ADVISORS, LLC | 04/07/2026 | 155.10 K | $279.18 K | 100.00% | 0.20% |
| DIAMETRIC CAPITAL, LP | 02/13/2026 | 138.93 K | $250.07 K | -22.81% | 0.18% |
| MORGAN STANLEY | 02/13/2026 | 131.99 K | $237.58 K | 85.80% | 0.17% |
| BARCLAYS PLC | 02/13/2026 | 112.85 K | $203.13 K | 10.86% | 0.14% |
| NUVEEN, LLC | 02/12/2026 | 90.19 K | $162.34 K | 0.00% | 0.11% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 79.00 K | $142.20 K | 84.45% | 0.10% |
| LAZARD ASSET MANAGEMENT LLC | 02/17/2026 | 71.39 K | $128.51 K | 100.00% | 0.09% |
| HRT FINANCIAL LP | 02/12/2026 | 64.61 K | $116.00 K | 100.00% | 0.08% |
| ORIN GREEN FINANCIAL, LLC | 02/06/2026 | 61.43 K | $110.58 K | 0.38% | 0.08% |
| INVESCO LTD. | 02/19/2026 | 50.56 K | $91.01 K | 12.35% | 0.06% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 46.35 K | $83.43 K | 130.39% | 0.06% |
| RHUMBLINE ADVISERS | 02/13/2026 | 44.37 K | $79.86 K | -31.94% | 0.06% |
| TWO SIGMA SECURITIES, LLC | 02/17/2026 | 39.81 K | $71.66 K | 100.00% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 38.52 K | $69.33 K | -47.18% | 0.05% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 35.28 K | $64.00 K | 0.00% | 0.04% |
| XTX TOPCO LTD | 02/17/2026 | 34.30 K | $61.73 K | -60.05% | 0.04% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/17/2026 | 33.25 K | $59.84 K | 3.08% | 0.04% |
| INTECH INVESTMENT MANAGEMENT LLC | 02/10/2026 | 31.13 K | $56.04 K | -0.37% | 0.04% |
| NEW YORK STATE COMMON RETIREMENT FUND | 02/12/2026 | 31.10 K | $55.98 K | -24.70% | 0.04% |
| JPMORGAN CHASE & CO | 02/11/2026 | 30.87 K | $55.57 K | 2.94% | 0.04% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 28.74 K | $51.47 K | 68.80% | 0.04% |
| CITADEL ADVISORS LLC | 02/17/2026 | 27.60 K | $49.68 K | 74.68% | 0.03% |
| APTUS CAPITAL ADVISORS, LLC | 02/13/2026 | 26.61 K | $47.90 K | 3.43% | 0.03% |
| CAPITAL PERFORMANCE ADVISORS LLP | 01/27/2026 | 25.98 K | $46.76 K | 0.00% | 0.03% |
| SMARTLEAF ASSET MANAGEMENT LLC | 02/13/2026 | 25.98 K | $45.20 K | 100.00% | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 02/17/2026 | 22.24 K | $40.04 K | -55.33% | 0.03% |
| STATE OF ALASKA, DEPARTMENT OF REVENUE | 01/23/2026 | 21.83 K | $39.00 K | 100.00% | 0.03% |
| MARSHALL WACE, LLP | 02/13/2026 | 19.08 K | $34.34 K | 100.00% | 0.02% |
| POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 02/13/2026 | 18.55 K | $33.40 K | 0.00% | 0.02% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/13/2026 | 18.50 K | $33.30 K | -23.10% | 0.02% |
| SG AMERICAS SECURITIES, LLC | 01/09/2026 | 17.16 K | $31.00 K | 100.00% | 0.02% |
Protalix BioTherapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 98 institutional investors and hedge funds held shares of Protalix BioTherapeutics Inc.. The most heavily invested institutionals were:
Stratos Wealth Partners, LTD.: 500,000
Prospera Financial Services Inc: 418,570
UBS Group AG: 265,535
Bank of New York Mellon Corp: 219,307
Nuveen, LLC: 90,188
Orin Green Financial, LLC: 64,433
18.80% of Protalix BioTherapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 15.77 M shares in the last 24 months. This purchase volume represents approximately $45.42 M in transactions.